The worldwide chronic heart failure therapeutics market is experiencing a period of marked growth. This rise can be attributed to the growing prevalence of chronic heart failure globally, coupled with developments in treatment alternatives. The market is characterized by a varied range of treatments, targeting different aspects of the disease. Majo